Sabra Healthcare REIT, Inc. (SBRA) Financials

Key financial figures for Sabra Healthcare REIT, Inc. (Q3 2026).

Sabra's Q3 2026 normalized AFFO was $0.41 per diluted share, up from $0.38 a year earlier, with same property SHOP Cash NOI up 14.6% year over year and full-year normalized AFFO guidance moved to $1.600 to $1.610. Total revenues were $249.6M versus $190.0M a year earlier (+31.3%, calculated from the release's income statement), led by resident fees and services of $143.2M versus $92.0M (+55.6%, calculated) as acquired senior housing operating portfolio (SHOP) communities came into the base. Per diluted share: GAAP net income $0.11 (vs $0.09), FFO $0.40 (vs $0.33), Normalized FFO $0.39 (vs $0.36), AFFO $0.45 (vs $0.37) and Normalized AFFO $0.41 (vs $0.38). FFO, AFFO and their normalized versions are company-defined non-GAAP measures. On the outlook: Full-year 2026 per diluted share, updated November 2, 2026 (prior range from the July 21, 2026 business update in parentheses): Net Income $0.265 to $0.275 ($0.37 to $0.39); FFO $1.145 to $1.155 ($1.12 to $1.14); Normalized FFO $1.540 to $1.550 ($1.53 to $1.55); AFFO $1.625 to $1.635 ($1.58 to $1.60); Normalized AFFO $1.600 to $1.610 ($1.59 to $1.61). Assumes mid-teens average full-year Cash NOI growth for same store SHOP, low-single-digit triple-net Cash NOI growth at the midpoint, G&A of $63M and cash interest expense of $106M at the midpoint, and only investments, dispositions and capital markets activity completed as of the release date. Figures are for Q3 2026, as Sabra Health Care REIT reported them.

Revenue

$250M

Net Income

$29M

EPS

$0.11

Total Assets

$5.4B

Operating Cash Flow

$129M

Full income statement, balance sheet and cash flow for Sabra Healthcare REIT, Inc. on SentiSense, with up to forty quarters and twenty fiscal years of history.